Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Alam Insider Profile
4 Followers
John Alam, EVP, Med. Dev. Group & CMO at Vertex Pharmaceuticals, holds 141.93K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds 1.46M shares in CervoMed (Ticker: CRVO). Most recently, John Alam ― shares of Vertex Pharmaceuticals on ― for an estimated value of ―.
John Alam has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Alam holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Alam
John Alam's Trading History
Vertex Pharmaceuticals
―
EVP, Med. Dev. Group & CMO
―
$64.86M
CervoMed
Nov 09, 2023
CEO & President, Director, Ten Percent Owner
Uninformative Sell
―
$27.32M
List of latest transactions for each holding click on a transaction to see John Alam's performance on stock
You May Also Like
John Alam insider profile FAQ
What is the percentage of profitable transactions made by John Alam?
The percentage of profitable transactions made by John Alam is ―.
What is the average return per transaction made by John Alam?
The average return per transaction made by John Alam is ―.
What stocks does John Alam hold?
John Alam holds: VRTX, CRVO stocks.
What was John Alam’s latest transaction?
John Alam latest transaction was an Uninformative Buy of ―.
What was John Alam's most profitable transaction?
John Alam’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Alam's role in Vertex Pharmaceuticals?
John Alam's role in Vertex Pharmaceuticals is EVP, Med. Dev. Group & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.